Gilead Sciences, Inc.
GILDNASDAQHealthcare● Active
$129.16
$-0.02(-0.02%)
Market Cap$160.4B
P/E Ratio—
52W High$157.29
52W Low$104.46
Gilead Sciences, Inc. (GILD) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · GILD · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $29.44B | $28.75B | $27.12B | $27.28B | $27.30B |
| Cost of Revenue | $6.23B | $6.25B | $6.50B | $5.66B | $6.60B |
| Gross Profit | $23.21B | $22.50B | $20.62B | $21.62B | $20.70B |
| Gross Margin %(computed) | 78.83% | 78.26% | 76.04% | 79.26% | 75.82% |
| Operating Expenses | |||||
| R&D Expenses | $5.80B | $5.91B | $5.72B | $4.98B | $4.60B |
| G&A Expenses | $2.19B | $2.64B | $2.82B | $4.89B | $4.51B |
| Total Operating Expenses | $11.51B | $20.84B | $13.01B | $14.29B | $10.79B |
| Operating Income | $11.70B | $1.66B | $7.61B | $7.33B | $9.92B |
| Operating Margin %(computed) | 39.74% | 5.78% | 28.05% | 26.87% | 36.32% |
| Interest Income | $0.35B | $0.28B | $0.38B | $0.11B | $0.00B |
| Interest Expense | $1.02B | $0.98B | $0.94B | $0.94B | $1.00B |
| Income Before Tax | $9.80B | $0.69B | $6.86B | $5.81B | $8.28B |
| Income Tax Expense | $1.29B | $0.21B | $1.25B | $1.25B | $2.08B |
| Net Income | $8.51B | $0.48B | $5.67B | $4.59B | $6.22B |
| Net Margin %(computed) | 28.90% | 1.67% | 20.89% | 16.83% | 22.80% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $6.84 | $0.38 | $4.54 | $3.66 | $4.96 |
| Wtd Avg Shares | 1.24B | 1.25B | 1.25B | 1.25B | 1.26B |
| EBITDA | $13.58B | $4.43B | $10.50B | $8.85B | $11.33B |
| EBITDA Margin %(computed) | 46.12% | 15.42% | 38.71% | 32.45% | 41.49% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Gilead Sciences, Inc. data
About Gilead Sciences, Inc. (GILD) Income Statement
Gilead Sciences, Inc. (GILD) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, GILD reported revenue of $29.44B, gross profit of $23.21B (gross margin 78.83%), and net income of $8.51B — a net profit margin of 28.90%.
Frequently asked questions
GILD · 4 questionsGilead Sciences, Inc. (GILD) reported revenue of $29.44B for 2025, up 2.4% year-over-year.
GILD revenueGILD salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08